Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Microbial Interactions: Parasitism01:22

Microbial Interactions: Parasitism

Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Inter-rater Variability in the Diagnosis of Urinary Tract Infections in the Emergency Department.

The western journal of emergency medicine·2026
Same author

XGBoost (eXtreme Gradient Boosting) Can Predict Organisms Growing in Urine Culture from the Emergency Department.

The western journal of emergency medicine·2026
Same author

Evolutionary history of Jamestown Canyon virus reveals complex multi-vector ecology.

Current biology : CB·2026
Same author

Tick lipocalin triggers mammalian IGFBP-3-mediated apoptosis in macrophages and keratinocytes.

Frontiers in immunology·2026
Same author

Discovery of an Adaptive Neuroimmune Response Driving Itch and Fast Tick Removal with Implications for Preventing Pathogen Transmission.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Evolutionary history of Jamestown Canyon virus disentangles complex multi-vector ecology.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: May 9, 2026

A Method for Evaluating Insecticide Efficacy against Bed Bug, Cimex lectularius, Eggs and First Instars
06:04

A Method for Evaluating Insecticide Efficacy against Bed Bug, Cimex lectularius, Eggs and First Instars

Published on: March 15, 2017

Ivermectin causes Cimex lectularius (bedbug) morbidity and mortality.

Johnathan M Sheele1, John F Anderson, Thang D Tran

  • 1Department of Emergency Medicine, Eastern Virginia Medical School and Emergency Physicians of Tidewater, Norfolk, Virginia 23507, USA.

The Journal of Emergency Medicine
|July 23, 2013
PubMed
Summary
This summary is machine-generated.

Ivermectin significantly increased bedbug mortality and prevented nymph molting in laboratory and human studies. This anti-parasitic drug shows potential for controlling bedbug infestations.

Keywords:
Cimex lectulariusbedbugivermectinmortalitypreventiontherapytreatment

More Related Videos

Methodology for Developing Life Tables for Sessile Insects in the Field Using the Whitefly, Bemisia tabaci, in Cotton As a Model System
09:23

Methodology for Developing Life Tables for Sessile Insects in the Field Using the Whitefly, Bemisia tabaci, in Cotton As a Model System

Published on: November 1, 2017

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Related Experiment Videos

Last Updated: May 9, 2026

A Method for Evaluating Insecticide Efficacy against Bed Bug, Cimex lectularius, Eggs and First Instars
06:04

A Method for Evaluating Insecticide Efficacy against Bed Bug, Cimex lectularius, Eggs and First Instars

Published on: March 15, 2017

Methodology for Developing Life Tables for Sessile Insects in the Field Using the Whitefly, Bemisia tabaci, in Cotton As a Model System
09:23

Methodology for Developing Life Tables for Sessile Insects in the Field Using the Whitefly, Bemisia tabaci, in Cotton As a Model System

Published on: November 1, 2017

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Area of Science:

  • Parasitology
  • Entomology
  • Clinical Pharmacology

Background:

  • Bedbug infestations are a growing public health concern in North America and Europe.
  • Physicians currently lack effective treatments for patients affected by bedbugs.

Purpose of the Study:

  • To investigate the efficacy of ivermectin, an oral anti-parasitic, in causing bedbug morbidity and mortality.
  • To assess ivermectin's potential as a bedbug infestation control agent.

Main Methods:

  • Evaluated ivermectin's effects on bedbugs using artificial feeding membranes, mice, and human subjects.
  • Recorded bedbug morbidity, mortality rates, and nymphal molting.
  • Administered ivermectin at dosages equivalent to human therapeutic levels.

Main Results:

  • Ivermectin achieved 98% bedbug mortality on artificial membranes and 86% in mice.
  • Bedbugs feeding on humans treated with ivermectin showed a 63% mortality rate within 20 days.
  • Ivermectin exposure completely inhibited nymphal molting in surviving bedbugs.

Conclusions:

  • Ivermectin demonstrates significant potential in reducing bedbug populations.
  • The drug may offer a novel strategy for eradicating, suppressing, or preventing bedbug infestations.